Tsiantoulas et al. [24] studied Apoe−/− and Ldlr−/− mice and found that anti-BAFF antibody treatment could deplete CD19(+)CD5(−) B cells and increased atherosclerosis. Here, CD19 is linked to atherosclerosis.